ATUM is an industry-leading provider of life science tools and solutions.
Founded as DNA2.0 in 2003, we were a pioneer in the application of machine learning to synthetic biology and currently hold multiple patents covering several technologies, including our first-to-market Leap-In Transposase® platform.
Our integrated offerings include Gene Design & Synthesis, Protein Production, and Cell Line Development — all powered by our Leap-In Transposase® and machine learning platform.
This means a streamlined path from sequence to Research Cell Bank (RCB) with just a click, ensuring efficiency, regulatory compliance, and innovative solutions tailored to our clients' needs. ATUM is privately held and is headquartered in Newark, CA.
